Tagged: Psychiatry

Culture as an effective frame of reference in clinical decision-making: A comparison of Iranian, American, and Canadian psychotherapists

Asian J Psychiatr. 2021 Nov 25;67:102928. doi: 10.1016/j.ajp.2021.102928. Online ahead of print. ABSTRACT The therapeutic communication between psychotherapist and client is highly dependent on their socio-cultural background. The purpose of this study was to examine the effects of culture on decision-making style of psychotherapists in three dimensions of decision-making: expedience vs. realism, individualism vs. collectivism, and long-term orientation vs. short-term orientation. The sample of this study consisted of 144 psychotherapists (40 Iranians educated in Iran, 33 Iranians educated in the west, 36 Americans, and 35 Canadians). Each of the participants were presented with three scenario that involved clinical challenging situations....

Review of Religious Variables in Advance Care Planning for End-of-Life Care: Consideration of Faith as a New Construct

The scientific evidence is quite clear that religious communities, religious practices, and religious and spiritual (R/S) values are important social determinants of health and important for “human flourishing” through maintaining and promoting the physical, spiritual and mental health needs of individuals. The data supporting the positive relationship of religion and health are important reminders for physicians and healthcare providers to consider religious beliefs and R/S values as foundational for patient-centered care, especially at end-of-life (EOL).


Late-onset depression (LOD), a depressive episode occurring for the first time in adults aged 65 years or older, is one of the most common neuropsychiatric disorders among older people.1-3 It has distinctive clinical features differentiating it from other types of depressive disorders, such as recurrent and early-onset depression4, and it has partially overlapping signs and symptoms with mild behavioral impairment5,6 and early-stage dementia.7-9 While distinctive clinical features raise the question of whether different types of depressive disorders present different biological markers, common clinical profiles between LOD and cognitive decline in old age raise the question of whether these two conditions...

Memory Supplements: Television Ads and the Elderly

The Food and Drug Administration’s (FDA) approval in June 2021 of the first new Alzheimer’s disease treatment in 18 years, aducanumab (Aduhelm), has been greeted with excitement and controversy in the media and in the medical community. The American Association of Geriatric Psychiatry (AAGP) has commented thoughtfully about this medication (1).

Enable Notifications    OK No thanks